{"id":"W3033326213","doi":"10.1007/s40744-020-00209-4","title":"Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study","year":2020,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada); Toronto Western Hospital; University of Toronto","funders":"National Institute for Health and Care Research; Pfizer","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Psoriatic arthritis; Tolerability; Adverse effect; Discontinuation; Internal medicine; Concomitant; Incidence (geometry); Interim analysis; Surgery; Arthritis; Clinical trial; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008197949,0.001021657,0.001987233,0.0005376765,0.0006492414,0.001530443,0.0006025131,0.0009289887,0.003717165],"category_scores_gemma":[0.004787003,0.0004239868,0.003290167,0.0005616829,0.0004523835,0.001253537,0.0004907858,0.002591591,0.0009467662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005189407,"about_ca_system_score_gemma":0.001266732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002407801,"about_ca_topic_score_gemma":0.0005271992,"domain_scores_codex":[0.9982079,0.0007582736,0.0001404601,0.000232456,0.0003700577,0.0002908689],"domain_scores_gemma":[0.995517,0.001009848,0.00159502,0.000630348,0.0004986131,0.0007491561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7841225,0.00852755,0.08597901,0.0009376701,0.005262306,0.0005239191,0.0002404222,0.001867454,0.01250019,0.000240773,0.005802354,0.09399572],"study_design_scores_gemma":[0.2344841,0.3483936,0.3697734,0.0002808689,0.01190609,0.00194133,0.0002366092,0.004868205,0.0111584,0.001541612,0.01523331,0.0001824713],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9791429,0.004691406,0.002014643,0.0004094688,0.0001426888,0.001827395,0.006625145,0.0002070624,0.004939273],"genre_scores_gemma":[0.9826013,0.0008087356,0.002149723,0.0007141316,0.0002195695,0.002156857,0.009223698,0.00004784314,0.002078068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008197949,"threshold_uncertainty_score":0.04335541,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02497477952717247,"score_gpt":0.3090752962793566,"score_spread":0.2841005167521841,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}